UK Earnings, Trading Statements Calendar | |
Friday, October 17 | |
Travis Perkins | Interim Management Statement |
Provident Financial | Interim Management Statement |
Record | Trading statement |
Monday, October 20 | |
McBride | Interim Management Statement |
Rolls-Royce Holdings | Medium Term Guidance |
Tuesday, October 21 | |
ASOS | Full Year Results |
William Hill | Interim Management Statement |
GKN | Interim Management Statement |
Polymetal International | Q3 Production Results |
Informa | Interim Management Statement |
ARM Holdings | Interim Management Statement |
Reckitt Benckiser | Interim Management Statement |
Go-Ahead Group | Interim Management Statement |
InterContinental Hotels Group | Interim Management Statement |
Devro | Interim Management Statement |
Wednesday, October 22 | |
City of London Investment Group | Interim Management Statement |
Senior | Interim Management Statement |
Development Securities | Half Year Results |
Petropavlovsk | Q3 Production Update |
Spirit Pub Company | Full Year Results |
British American Tobacco | Interim Management Statement |
Computacenter | Interim Management Statement |
GlaxoSmithKline | Q3 Results |
Home Retail Group | Half Year Results |
International Personal Finance | Interim Management Statement |
Laird | Interim Management Statement |
Playtech | Interim Management Statement |
Thursday, October 23 | |
Phoenix Group Holdings | Interim Management Statement |
Volution Group | Full Year Results |
Mountview Estates | Full Year Results |
Tesco | Half Year Results |
Ladbrokes | Interim Management Statement |
Mecom Group | Interim Management Statement |
Britivic | Interim Management Statement |
Anglo American | Q3 Production Report |
Foreign & Colonial Investment Trust | Interim Management Statement |
Bloomsbury Publishing | Half Year Results |
Inchcape | Interim Management Statement |
Segro | Interim Management Statement |
St James's Place | Interim Management Statement |
Stobart Group | Half Year Results |
Unilever | Q3 Results |
SVG Capital | Interim Management Statement |
African Barrick Gold | Q3 Results |
Colt Group | Interim Management Statement |
National Express Group | Interim Management Statement |
Premier Foods | Interim Management Statement |
Reed Elsevier | Interim Management Statement |
Photo-Me International | Trading Statement |
Copyright 2014 Alliance News Limited. All Rights Reserved. | |
![Sharecast News](https://static.lse.co.uk/images/news-logos/sharecast-news-logo.png)
GSK's Jemperli sees success in endometrial cancer trial
(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.
Read more